EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model

Robert S Leddy, Cinthia L Hudachek, Hannah M Phelan, Carol M Aherne iD, Julián Romero, Cecilia J Hillard, Zhiran Wang, Günther Eissner, Paul Jedlicka iD, Colm B Collins iD

Inflammatory Bowel Diseases · 2026

DOI: 10.1093/ibd/izag066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Robert S Leddy und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB2, Ileitis, Crohn Disease, T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Senior Research award from the Crohn's and Colitis Foundation, UCD Ad Astra Fellowship, Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leukocyte trafficking is a critical step in the development of chronic intestinal diseases such as Crohn’s disease. While strategies that block gut homing have yielded partial success, this disease remains uncurable leaving an unmet clinical need. This is the first paper to describe a role for cannabinoid receptor 2 (CB2R) signaling in promoting retinoic acid-mediated induction of the gut homing associated integrin heterodimer α4β7. Using in vitro and in vivo models, we characterized the effects of pharmacological CB2R agonists and inverse agonists on T cell homing receptor expression and transmigration across gut-associated endothelial barriers. This extracellular signal-regulated kinase–dependent process coincides with increased T cell adherence in response to CB2R agonism with JWH-133. These effects were reversed with an inverse agonist GP-1a in a CB2R dependent manner. Selective deletion of CB2R using CRISPR in vitro or CD4Cre/+ floxed mice in vivo resulted in impaired endothelial cell adherence and decreased diapedesis into the ileal lamina propria. T cell–specific deletion of CNR2, the gene encoding CB2R, attenuated chronic murine ileitis characterized by decreased naïve T cell infiltration and loss of tissue architecture in 20-week-old TNFΔARE/+ mice. This study supports further therapeutic development of CB2R-targeting drugs for the treatment of inflammatory bowel disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB2IleitisCrohn DiseaseT-LymphocytesAnimalsMiceDisease Models, AnimalHumansMice, Inbred C57BLCell AdhesionMice, KnockoutIntegrinsFemale

Stichwörter der Autor:innen

CB2RT cell adherencecannabinoidschronic ileitis

Substanzen

Receptor, Cannabinoid, CB2integrin alpha4beta7Cnr2 protein, mouseIntegrins

Autor:innen und Institutionen

  • School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Section of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • School of Medicine, University College Dublin, Dublin, Ireland.
  • Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Spain.
  • Department of Pharmacology and Toxicology, Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI, United States.

ORCID-Profile: Carol M Aherne, Paul Jedlicka, Colm B Collins

Förderung

  • Senior Research award from the Crohn's and Colitis Foundation
  • UCD Ad Astra Fellowship
  • Ministerio de Ciencia e Innovación-Agencia Estatal de Investigación
  • Fondo Europeo de Desarrollo Regional
  • FEDER
  • Crohn's and Colitis Foundation
  • Crohn’s and Colitis Foundation

Zitieren

APA

Leddy, R. S., Hudachek, C. L., Phelan, H. M., Aherne, C. M., Romero, J., Hillard, C. J., Wang, Z., Eissner, G., Jedlicka, P., & Collins, C. B. (2026). CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag066

Vancouver

Leddy RS, Hudachek CL, Phelan HM, Aherne CM, Romero J, Hillard CJ, et al. CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag066

BibTeX
@article{Leddy2026,
  author = {Leddy, Robert S and Hudachek, Cinthia L and Phelan, Hannah M and Aherne, Carol M and Romero, Julián and Hillard, Cecilia J and Wang, Zhiran and Eissner, Günther and Jedlicka, Paul and Collins, Colm B},
  title = {CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  doi = {10.1093/ibd/izag066}
}
Kostenlos starten →